These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2312684)

  • 41. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group. Danish study group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1994 Jun; 102(6):446-50. PubMed ID: 8068304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.
    Snydman DR; Jacobus NV; McDermott LA; Supran S; Cuchural GJ; Finegold S; Harrell L; Hecht DW; Iannini P; Jenkins S; Pierson C; Rihs J; Gorbach SL
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2417-22. PubMed ID: 10508018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM; Finegold SM
    J Chemother; 1991 Feb; 3 Suppl 2():12-9. PubMed ID: 2040893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of the BD Phoenix100 System and Colistin Broth Disk Elution Method for Antimicrobial Susceptibility Testing of Colistin Against Gram-negative Bacteria].
    Koyuncu Özyurt Ö; Özhak B; Öğünç D; Yıldız E; Çolak D; Günseren F; Öngüt G
    Mikrobiyol Bul; 2019 Jul; 53(3):254-261. PubMed ID: 31414627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.
    Turgeon P; Turgeon V; Gourdeau M; Dubois J; Lamothe F
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2276-9. PubMed ID: 7840557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.
    Wasilauskas BL
    Diagn Microbiol Infect Dis; 1989; 12(1):39-43. PubMed ID: 2714071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae.
    Macias EA; Mason EO; Ocera HY; LaRocco MT
    J Clin Microbiol; 1994 Feb; 32(2):430-2. PubMed ID: 8150953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: validation report from the SENTRY Antimicrobial Surveillance Program.
    Pottumarthy S; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):57-62. PubMed ID: 15629230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility of the Bacteroides fragilis group in the United States in 1981.
    Tally FP; Cuchural GJ; Jacobus NV; Gorbach SL; Aldridge KE; Cleary TJ; Finegold SM; Hill GB; Iannini PB; McCloskey RV; O'Keefe JP; Pierson CL
    Antimicrob Agents Chemother; 1983 Apr; 23(4):536-40. PubMed ID: 6859833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.
    Betriu C; Campos E; Cabronero C; Rodriguez-Avial C; Picazo JJ
    Antimicrob Agents Chemother; 1990 Apr; 34(4):671-3. PubMed ID: 2344174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values.
    Aldridge KE; Weeks LS; Stratton CW; Sanders CV
    Diagn Microbiol Infect Dis; 1990; 13(4):311-6. PubMed ID: 2076592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.
    Aldridge KE; O'Brien M
    J Clin Microbiol; 2002 Nov; 40(11):4349-52. PubMed ID: 12409429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.
    Pillar CM; Stoneburner A; Shinabarger DL; Abbeloos E; Goby L; Bradley AJ
    J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
    O'Keefe JP; Venezio FR; DiVincenzo CA; Shatzer KL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2002-4. PubMed ID: 3439807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Broth disk elution method for anaerobic bacteria: a collaborative study to assess its reliability for clinical purposes.
    Bianchini H; Canigia LF; Predari SC; Rollet R; Litterio M; Berestein P; Castello L; De Martino A; Greco G; Hardie N
    Anaerobe; 1997 Aug; 3(4):225-31. PubMed ID: 16887595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disk diffusion susceptibility testing of the Bacteroides fragilis group.
    Horn R; Bourgault AM; Lamothe F
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1596-9. PubMed ID: 3481247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods.
    Jones RN; Barry AL; Fuchs PC; Thornsberry C
    J Clin Microbiol; 1986 Dec; 24(6):1055-9. PubMed ID: 3097064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.